首页> 外文OA文献 >Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem

【2h】

Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem

机译：患有乳腺癌的靶向拉帕替尼抗HER2 / ERBB2治疗抵抗力：机会克服难题

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
Reema Wahdan-Alaswad; Bolin Liu; Ann D. Thor;
展开▼
作者单位

展开▼
年度 2020
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Nonamplification ERBB2 genomic alterations in 5605 cases of recurrent and metastatic breast cancer: An emerging opportunity for anti-HER2 targeted therapies [J] . Ross Jeffrey S., Gay Laurie M., Wang Kai, Cancer: A Journal of the American Cancer Society . 2016,第17期

机译：5605例复发和转移性乳腺癌中的非扩增性ERBB2基因组改变：抗HER2靶向治疗的新兴机会
2. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer [J] . Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi, Nature Communications . 2018,第1期

机译：靶向17q23扩增子以克服对HER2 +乳腺癌的抗HER2治疗的耐药性
3. A SYSTEMS PHARMACOLOGY MODEL TO EVALUATE TRIPLE DRUG COMBINATION THERAPY AT OVERCOMING RESISTANCE TO ANTI-HER2 THERAPY IN HER2-POSITIVE BREAST CANCER. [J] . Franco Y., Ramakrishnan V., Vaidya T., Clinical Pharmacology and Therapeutics . 2020,第S1期

机译：一种系统药理学模型，评价三重药物联合治疗在耐乳癌抗Her2疗法耐抗Her2疗法中的抗性。
4. Preparation and Characterization of PE38KDEL-Loaded anti-HER2 modified nanoparticles for targeted cancer therapy [C] . LI Zhong, rnCHEN Haiming, rnSUN Fuxue, Novel Drug Delivery Systems: Research and Application . 2007

机译：载有PE38KDEL的抗HER2修饰纳米粒的制备及表征
5. Role of Lapatinib and Retinoids In Overcoming Intrinsic Resistance to Hormonal Therapy In Breast Cancer [D] . Gilani, Rabia Afzal 2011

机译：拉帕替尼和类维生素A在克服乳腺癌激素治疗的内在抗性中的作用
6. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer [O] . Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi, -1

机译：靶向17q23扩增子以克服对HER2 +乳腺癌的抗HER2治疗的耐药性
7. Targeting 17q23 amplicon to overcome the resistance to anti-HER2 therapy in HER2+ breast cancer [O] . Yunhua Liu, Jiangsheng Xu, Hyun Ho Choi, 2018

机译：靶向17 Q23扩增子以克服HER2 +乳腺癌抗HER2治疗的抵抗力

Targeted lapatinib anti-HER2/ErbB2 therapy resistance in breast cancer: opportunities to overcome a difficult problem

著录项

引文网络

相似文献

相关主题

期刊订阅